Serologic response to measles-mumps-rubella vaccine among children with upper respiratory tract infection

By Cilla G.   Pena B.   Marimon J.M.   Perez-Trallero E.  

Vaccine, Vol. 14, Iss. 6, 1996-04 ,pp. : 492-494

Elsevier

Access to resources Recommend Favorite

Seroconversion of a trivalent measles, mumps, and rubella vaccine in children aged 9 and 15 months

By Forleo-Neto E.   Carvalho E.S.   Fuentes I.C.P.   Precivale M.S.   Forleo L.H.A.   Farhat C.K.  

Vaccine, Vol. 15, Iss. 17, 1997-12 ,pp. : 1898-1901

Elsevier

Access to resources Recommend Favorite

Specific IgG to gelatin in children with systemic immediate- and nonimmediate-type reactions to measles, mumps and rubella vaccines

By Miyazawa H.   Saitoh S.   Kumagai T.   Yamanaka T.   Yasuda S.   Tsunetsugu-Yokota Y.   Inouye S.   Sakaguchi M.  

Vaccine, Vol. 17, Iss. 17, 1999-04 ,pp. : 2176-2180

Elsevier

Access to resources Recommend Favorite

Comparison of immunogenicity and reactogenicity of a measles, mumps and rubella (MMR) vaccine in German children vaccinated at 9-11, 12-14 or 15-17 months of age *

By Klinge  

Vaccine, Vol. 18, Iss. 27, 2000-07 ,pp. : 3134-3140

Elsevier

Access to resources Recommend Favorite

Measles, mumps, and rubella antibodies in children 5-6 years after immunization: effect of vaccine type and age at vaccination

By Boulianne N.   De Serres G.   Duval B.   Ratnam S.   Ward B.J.   Joly J.R.  

Vaccine, Vol. 13, Iss. 16, 1995-11 ,pp. : 1611-1616

Elsevier

Access to resources Recommend Favorite